Core Insights - The article highlights the innovative advancements of Xianle Health at the recent China International Import Expo (CIIE), showcasing their WELMAX evidence-based nutrition technology platform and a focus on six high-potential sectors [1][2] - Xianle Health emphasizes the integration of artificial intelligence in their product development, enabling personalized nutrition solutions through AI nutritionists [1] - The company has initiated strategic collaborations, including a partnership with doTERRA to co-develop essential oil-infused nutritional health products [1][2] Group 1 - Xianle Health launched multiple new products at the CIIE, leveraging the WELMAX platform to create a comprehensive evidence-based approach from raw material selection to product launch [2] - The company is collaborating with the China National Institute of Standardization and the China Nutrition and Health Food Association to establish a group standard for DHA algal oil nutritional product formulation and production technology [2] - Clinical evidence is a cornerstone of the WELMAX platform, with partnerships established with top-tier hospitals to conduct high-quality clinical research, ensuring authoritative validation of product value [2] Group 2 - The CIIE serves as a platform for Xianle Health to introduce diverse cross-border solutions, enhancing the accessibility of global nutritional resources [1] - The health and wellness sector is being redefined through innovative technologies, with a focus on creating new experiences in nutritional supplementation [1] - Xianle Health aims to continue fostering a new ecosystem of nutrition, contributing to high-quality industry development [2]

Core Insights - Xianle Health showcased its commitment to the nutrition and health sector by participating in the 8th China International Import Expo, marking its fifth appearance at this national-level exhibition [2] - The company launched the WELMAX evidence-based nutrition technology platform, aimed at addressing the trust crisis and homogenization issues in the nutrition health food industry, redefining the standards of "effectiveness" [2] - Xianle Health's General Manager emphasized the importance of the expo as a platform for global cooperation and industry innovation, highlighting the company's strategic focus on evidence-driven development [2] Industry Developments - Xianle Health announced collaborations with authoritative organizations to initiate two key standard projects: a white paper on "Scientific Evidence and Grading of Health Benefits of Foods and Ingredients" in partnership with the Chinese Nutrition Society, and a group standard for "DHA Algal Oil Nutritional Product Formulation Design and Production Processing Technology Guidelines" in collaboration with the China Standardization Research Institute and the China Nutrition Health Food Association [3] - Established in 1993, Xianle Health is a globally recognized contract R&D manufacturer in the nutrition health food sector, providing comprehensive solutions including research, product development, manufacturing, packaging, logistics, and marketing support [3] - The company went public on the Shenzhen Stock Exchange's Growth Enterprise Market in 2019, becoming the first A-share listed CDMO enterprise in the nutrition health food industry [3]